Kidney Cancer Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065281
  • May 2021
  • Pharmaceuticals
  • 118 Pages
The global Kidney Cancer Drugs market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Kidney Cancer Drugs market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Kidney Cancer Drugs market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Kidney Cancer Drugs market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Pfizer Inc., Novartis AG, Bayer AG, Genentech, Inc., Bristol-Myers Squibb Company, Exelixis, Inc., Eisai Co. , Ltd., Prometheus Laboratories Inc., GlaxoSmithKline plc, F. Hoffmann La Roche Ltd.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Kidney Cancer Drugs market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Kidney Cancer Drugs market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Kidney Cancer Drugs market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Kidney Cancer Drugs market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Kidney Cancer Drugs Market:
The Kidney Cancer Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Pfizer Inc., Novartis AG, Bayer AG, Genentech, Inc., Bristol-Myers Squibb Company, Exelixis, Inc., Eisai Co. , Ltd., Prometheus Laboratories Inc., GlaxoSmithKline plc, F. Hoffmann La Roche Ltd.

Kidney Cancer Drugs Market Segment Analysis:
By Therapeutic Class
Targeted Therapy
Immunotherapy
Pharmacologic Class
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy
IL-2

Geographic Coverage for Kidney Cancer Drugs Market:
The market research report on global Kidney Cancer Drugs market offers complete analysis across various regions across the world. The Kidney Cancer Drugs market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Kidney Cancer Drugs market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Kidney Cancer Drugs Market Value and Forecast
  • US
  • Canada
Europe Kidney Cancer Drugs Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Kidney Cancer Drugs Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Kidney Cancer Drugs Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Kidney Cancer Drugs Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Kidney Cancer Drugs market report:
  • The report provides key trends of the global Kidney Cancer Drugs market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Kidney Cancer Drugs industry
  • The report covers all the recent developments of the Kidney Cancer Drugs market and helps to provide current industry updates
  • The report covers a detailed look over the global Kidney Cancer Drugs Industry and provides with significant actionable insights
  • The Kidney Cancer Drugs market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Kidney Cancer Drugs market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Kidney Cancer Drugs market
  • Comprehensive analysis of the Kidney Cancer Drugs market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Kidney Cancer Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Kidney Cancer Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Kidney Cancer Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Kidney Cancer Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Kidney Cancer Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Genentech, Inc.
  • Bristol-Myers Squibb Company
  • Exelixis, Inc.
  • Eisai Co. , Ltd.
  • Prometheus Laboratories Inc.
  • GlaxoSmithKline plc
  • F. Hoffmann La Roche Ltd.
  • Targeted Therapy
  • Immunotherapy
  • Angiogenesis Inhibitors
  • mTOR Inhibitors
  • Monoclonal Antibodies
  • Cytokine Immunotherapy
  • IL-2

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Kidney Cancer Drugs Market Snapshot
          2.1.1. Global Kidney Cancer Drugs Market By Therapeutic Class,2019
               2.1.1.1.Targeted Therapy
               2.1.1.2.Immunotherapy
          2.1.2. Global Kidney Cancer Drugs Market By Pharmacologic Class,2019
               2.1.2.1.Angiogenesis Inhibitors
               2.1.2.2.mTOR Inhibitors
               2.1.2.3.Monoclonal Antibodies
               2.1.2.4.Cytokine Immunotherapy
               2.1.2.5.IL-2
          2.1.3. Global Kidney Cancer Drugs Market By End-use,2019
          2.1.4. Global Kidney Cancer Drugs Market By Geography,2019

3. Global Kidney Cancer Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Therapeutic Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Therapeutic Class, 2020
     4.2. Global Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028

5. Global Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Pharmacologic Class, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Pharmacologic Class, 2020
     5.2. Global Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028

6. Global Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Kidney Cancer Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Kidney Cancer Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Kidney Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028
          7.2.3. North America Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028
          7.2.4. North America Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Kidney Cancer Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Kidney Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028
          7.3.3. Europe Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028
          7.3.4. Europe Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Kidney Cancer Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Kidney Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028
          7.4.3. Asia Pacific Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028
          7.4.4. Asia Pacific Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Kidney Cancer Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Kidney Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028
          7.5.3. Latin America Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028
          7.5.4. Latin America Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Kidney Cancer Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Kidney Cancer Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Kidney Cancer Drugs Market Size (US$), By Therapeutic Class, 2018 – 2028
          7.6.3. MEA Kidney Cancer Drugs Market Size (US$), By Pharmacologic Class, 2018 – 2028
          7.6.4. MEA Kidney Cancer Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Kidney Cancer Drugs Providers
        8.4.1 Pfizer Inc.
                8.4.1.1 Business Description
                8.4.1.2 Pfizer Inc. Geographic Operations
                8.4.1.3 Pfizer Inc. Financial Information
                8.4.1.4 Pfizer Inc. Product Positions/Portfolio
                8.4.1.5 Pfizer Inc. Key Developments
        8.4.2 Novartis AG
                8.4.2.1 Business Description
                8.4.2.2 Novartis AG Geographic Operations
                8.4.2.3 Novartis AG Financial Information
                8.4.2.4 Novartis AG Product Positions/Portfolio
                8.4.2.5 Novartis AG Key Developments
        8.4.3 Bayer AG
                8.4.3.1 Business Description
                8.4.3.2 Bayer AG Geographic Operations
                8.4.3.3 Bayer AG Financial Information
                8.4.3.4 Bayer AG Product Positions/Portfolio
                8.4.3.5 Bayer AG Key Developments
        8.4.4 Genentech, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Genentech, Inc. Geographic Operations
                8.4.4.3 Genentech, Inc. Financial Information
                8.4.4.4 Genentech, Inc. Product Positions/Portfolio
                8.4.4.5 Genentech, Inc. Key Developments
        8.4.5 Bristol-Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol-Myers Squibb Company Financial Information
                8.4.5.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol-Myers Squibb Company Key Developments
        8.4.6 Exelixis, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Exelixis, Inc. Geographic Operations
                8.4.6.3 Exelixis, Inc. Financial Information
                8.4.6.4 Exelixis, Inc. Product Positions/Portfolio
                8.4.6.5 Exelixis, Inc. Key Developments
        8.4.7 Eisai Co. , Ltd.
                8.4.7.1 Business Description
                8.4.7.2 Eisai Co. , Ltd. Geographic Operations
                8.4.7.3 Eisai Co. , Ltd. Financial Information
                8.4.7.4 Eisai Co. , Ltd. Product Positions/Portfolio
                8.4.7.5 Eisai Co. , Ltd. Key Developments
        8.4.8 Prometheus Laboratories Inc.
                8.4.8.1 Business Description
                8.4.8.2 Prometheus Laboratories Inc. Geographic Operations
                8.4.8.3 Prometheus Laboratories Inc. Financial Information
                8.4.8.4 Prometheus Laboratories Inc. Product Positions/Portfolio
                8.4.8.5 Prometheus Laboratories Inc. Key Developments
        8.4.9 GlaxoSmithKline plc
                8.4.9.1 Business Description
                8.4.9.2 GlaxoSmithKline plc Geographic Operations
                8.4.9.3 GlaxoSmithKline plc Financial Information
                8.4.9.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.9.5 GlaxoSmithKline plc Key Developments
        8.4.10 F. Hoffmann La Roche Ltd.
                8.4.10.1 Business Description
                8.4.10.2 F. Hoffmann La Roche Ltd. Geographic Operations
                8.4.10.3 F. Hoffmann La Roche Ltd. Financial Information
                8.4.10.4 F. Hoffmann La Roche Ltd. Product Positions/Portfolio
                8.4.10.5 F. Hoffmann La Roche Ltd. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Kidney Cancer Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Kidney Cancer Drugs Market Revenue, By Therapeutic Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Kidney Cancer Drugs Market Revenue, By Pharmacologic Class, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Kidney Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Kidney Cancer Drugs Market Revenue, By Therapeutic Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Kidney Cancer Drugs Market Revenue, By Pharmacologic Class, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Kidney Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Kidney Cancer Drugs Market Revenue, By Therapeutic Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Kidney Cancer Drugs Market Revenue, By Pharmacologic Class, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Kidney Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Kidney Cancer Drugs Market Revenue, By Therapeutic Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Kidney Cancer Drugs Market Revenue, By Pharmacologic Class, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Kidney Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Kidney Cancer Drugs Market Revenue, By Therapeutic Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Kidney Cancer Drugs Market Revenue, By Pharmacologic Class, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Kidney Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Kidney Cancer Drugs: Market Segmentation 
FIG. 2 Global Kidney Cancer Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Kidney Cancer Drugs Market, By Therapeutic Class, 2019 (US$ Mn) 
FIG. 5 Global Kidney Cancer Drugs Market, By Pharmacologic Class, 2019 (US$ Mn) 
FIG. 6 Global Kidney Cancer Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Kidney Cancer Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Kidney Cancer Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Kidney Cancer Drugs Providers, 2019
FIG. 11 Global Kidney Cancer Drugs Market Revenue Contribution, By Therapeutic Class, 2019 & 2028 (Value %) 
FIG. 12 Global Kidney Cancer Drugs Market Revenue Contribution, By Pharmacologic Class, 2019 & 2028 (Value %) 
FIG. 13 Global Kidney Cancer Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Kidney Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Kidney Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Kidney Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Kidney Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Kidney Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Kidney Cancer Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Kidney Cancer Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Kidney Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Kidney Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Kidney Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Kidney Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Kidney Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Kidney Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Kidney Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Kidney Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Kidney Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Kidney Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Kidney Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Kidney Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Kidney Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Kidney Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Kidney Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genentech, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Exelixis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eisai Co. , Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Prometheus Laboratories Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Kidney Cancer Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Kidney Cancer Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Kidney Cancer Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Kidney Cancer Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Kidney Cancer Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Kidney Cancer Drugs Providers, 2016
FIG.  Global Kidney Cancer Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Kidney Cancer Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global mTOR Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Monoclonal Antibodies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cytokine Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global IL-2 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Kidney Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)